• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4622684)   Today's Articles (294)   Subscriber (49406)
For: Jirathitikal V, Metadilogkul O, Bourinbaiar AS. Increased body weight and improved quality of life in AIDS patients following V-1 Immunitor administration. Eur J Clin Nutr 2003;58:110-5. [PMID: 14679375 DOI: 10.1038/sj.ejcn.1601756] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Number Cited by Other Article(s)
1
Serodeconversion of HIV antibody-positive AIDS patients following treatment with V-1 Immunitor. J Biomed Biotechnol 2008;2009:934579. [PMID: 18989372 PMCID: PMC2577775 DOI: 10.1155/2009/934579] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2008] [Revised: 08/07/2008] [Accepted: 09/07/2008] [Indexed: 11/17/2022]  Open
2
Del Fabbro E, Dalal S, Bruera E. Symptom control in palliative care--Part II: cachexia/anorexia and fatigue. J Palliat Med 2006;9:409-21. [PMID: 16629571 DOI: 10.1089/jpm.2006.9.409] [Citation(s) in RCA: 43] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]  Open
3
Bourinbaiar AS, Abulafia-Lapid R. Clinical experience with therapeutic AIDS vaccines. Expert Rev Vaccines 2006;4:289-304. [PMID: 16026245 DOI: 10.1586/14760584.4.3.289] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
4
Metadilogkul O, Jirathitikal V, Bourinbaiar AS. Prolonged survival of end-stage AIDS patients immunized with therapeutic HIV vaccine V-1 Immunitor. Biomed Pharmacother 2005;59:469-73. [PMID: 16126364 DOI: 10.1016/j.biopha.2005.07.004] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2005] [Indexed: 10/25/2022]  Open
5
Bourinbaiar AS, Jirathitikal V, Metadilogkul O, Sooksathan P, Paiboon P, Aemsri S, Prapai P, Chaodon K. Phase II placebo-controlled study of V-1 Immunitor as a therapeutic modality for treatment of HIV. J Clin Virol 2004;31 Suppl 1:S55-62. [PMID: 15567095 DOI: 10.1016/j.jcv.2004.09.002] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
6
Thongcharoen P. The oral AIDS vaccine,V-1 Immunitor. HIV CLINICAL TRIALS 2004;5:257-8. [PMID: 15472800 DOI: 10.1310/cfqc-feja-w3d0-8cq1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
7
Thongcharoen P. V-1 immunitor. Viral Immunol 2004;17:457. [PMID: 15357913 DOI: 10.1089/vim.2004.17.457] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
8
Bourinbaiar AS, Metadilogkul O, Jirathitikal V. Mucosal AIDS vaccines. Viral Immunol 2004;16:427-45. [PMID: 14733732 DOI: 10.1089/088282403771926274] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]  Open
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA